Rob Smallman
President
Expert in cannabis cultivation with over 24 years of experience
Rob Smallman is a seasoned expert in medical cannabis cultivation, post-harvest operations, and international trade, with over 24 years of experience leading large-scale projects across North America, Europe, and beyond. As Vice President of the Global Cannabis Exchange (GCX), he plays a pivotal role in connecting international buyers and suppliers, ensuring compliance, quality assurance, and seamless transactions in the evolving cannabis marketplace. His expertise spans licensing, facility design, genetic development, and regulatory frameworks, helping businesses navigate the complexities of global cannabis markets.
Prior to GCX, Rob served as Principal Consultant for Medical Cannabis & B2B and Director of Cultivation & Post-Harvest for Curaleaf International, overseeing B2B sales, supply chain management, and product development. He has advised on regulatory compliance, facility optimization, and genetic strategies in Spain, Italy, Portugal, Canada, Thailand, Switzerland, and Uruguay. He was also instrumental in shaping Canadian cannabis regulations, contributing to MMPR, ACMPR, and MMAR programs, which set industry benchmarks.
Beyond cannabis, Rob is a leading advocate for psilocybin research and mycelium-based treatments, believing in their potential to drive innovation in alternative medicine and mental health therapies. His deep industry knowledge, strategic leadership, and commitment to compliance continue to shape the future of the medical cannabis industry.